---

THIS WARRANT AND THE SHARES ISSUABLE
HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY
NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF
UNDER SUCH ACT OR PURSUANT TO RULE 144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO
THE CORPORATION AND ITS COUNSEL THAT SUCH REGISTRATION IS NOT REQUIRED.

|                        |  | WARRANT TO PURCHASE STOCK                   | 
|----------------------- |  | ------------------------------------------- | 
|                        |  |                                             | 
|Corporation:            |  | TCI SOLUTIONS, INC., a Delaware Corporation | 
|Number of Shares:       |  | 35,000                                      | 
|Class of Stock:         |  | Common                                      | 
|Initial Exercise Price: |  | $0.25 per share                             | 
|Issue Date:             |  | February 27, 2004                           | 
|Expiration Date:        |  | February 27, 2011 (Subject to Section 4.1)  | 

THIS
WARRANT CERTIFIES THAT, for good and valuable consideration, the receipt of which is
hereby acknowledged, COMERICA BANK or its assignee (Holder) is entitled to
purchase the number of fully paid and nonassessable shares of the class of securities (the
Shares) of the corporation (the Company) at the initial exercise
price per Share (the Warrant Price) all as set forth above and as adjusted
pursuant to Article 2 of this warrant, subject to the provisions and upon the terms and
conditions set forth in this warrant.

ARTICLE 1.   EXERCISE.

1.1  
Method of Exercise. Holder may exercise this warrant by delivering this warrant and
a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the
principal office of the Company. Unless Holder is exercising the conversion right set
forth in Section 1.2, Holder shall also deliver to the Company a check for the aggregate
Warrant Price for the Shares being purchased.

1.2  
Conversion Right. In lieu of exercising this warrant as specified in
Section 1.1, Holder may from time to time convert this warrant, in whole or in part,
into a number of Shares determined by dividing (a) the aggregate fair market value of
the Shares or other securities otherwise issuable upon exercise of this warrant minus the
aggregate Warrant Price of such Shares by (b) the fair market value of one Share. The
fair market value of the Shares shall be determined pursuant to Section 1.4.

1.3  
Intentionally Omitted.

1.4  
Fair Market Value. If the Shares are traded regularly in a public market, the fair
market value of the Shares shall be the closing price of the Shares (or the closing price
of the Companys stock into which the Shares are convertible) reported for the
business day immediately before Holder delivers its Notice of Exercise to the Company. If
the Shares are not regularly traded in a public market, the Board of Directors of the
Company shall determine fair market value in its reasonable good faith judgment.

-1-



---

1.5  
Delivery of Certificate and New Warrant. Promptly after Holder exercises or
converts this warrant, the Company shall deliver to Holder certificates for the Shares
acquired and, if this warrant has not been fully exercised or converted and has not
expired, a new warrant representing the Shares not so acquired.

1.6  
Replacement of Warrants. On receipt of evidence reasonably satisfactory to the
Company of the loss, theft, destruction or mutilation of this warrant and, in the case of
loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory
in form and amount to the Company or, in the case of mutilation, on surrender and
cancellation of this warrant, the Company at its expense shall execute and deliver, in
lieu of this warrant, a new warrant of like tenor.

1.7  
Repurchase on Sale, Merger, or Consolidation of the Company.

1.7.1  
Acquisition. For the purpose of this warrant, Acquisition
means any sale, license, or other disposition of all or substantially all of the assets
(including intellectual property) of the Company, or any reorganization, consolidation, or
merger of the Company where the holders of the Companys securities before the
transaction beneficially own less than 50% of the outstanding voting securities of the
surviving entity after the transaction.

1.7.2  
Assumption of Warrant. If upon the closing of any Acquisition the successor entity
assumes the obligations of this warrant, then this warrant shall be exercisable for the
same securities, cash, and property as would be payable for the Shares issuable upon
exercise of the unexercised portion of this warrant as if such Shares were outstanding on
the record date for the Acquisition and subsequent closing. The Warrant Price shall be
adjusted accordingly. The Company shall use reasonable efforts to cause the surviving
corporation to assume the obligations of this warrant.

1.7.3  
Nonassumption. If upon the closing of any Acquisition the successor entity does not
assume the obligations of this warrant and Holder has not otherwise exercised this warrant
in full, then this warrant shall be deemed to have been automatically converted pursuant
to Section 1.2 and thereafter Holder shall participate in the Acquisition on the same
terms as other holders of the same class of securities of the Company.

ARTICLE 2.  ADJUSTMENTS TO THE
SHARES.

2.1  
Stock Dividends, Splits, Etc. If the Company declares or pays a dividend on its
common stock payable in common stock, or other securities, subdivides the outstanding
common stock into a greater amount of common stock, then upon exercise of this warrant,
for each Share acquired, Holder shall receive, without cost to Holder, the total number
and kind of securities to which Holder would have been entitled had Holder owned the
Shares of record as of the date the dividend or subdivision occurred.

2.2  
Reclassification, Exchange or Substitution. Upon any reclassification, exchange,
substitution, or other event that results in a change of the number and/or class of the
securities issuable upon exercise or conversion of this warrant, Holder shall be entitled
to receive, upon exercise or conversion of this warrant, the number and kind of securities
and property that Holder would have received for the Shares if this warrant had been
exercised immediately before

-2-



---

such reclassification, exchange, substitution, or other
event. Such an event shall include any automatic conversion of the outstanding or issuable
securities of the Company of the same class or series as the Shares to common stock
pursuant to the terms of the Companys Certificate of Incorporation upon the closing
of a registered public offering of the Companys common stock. The Company or its
successor shall promptly issue to Holder a new warrant for such new securities or other
property. The new warrant shall provide for adjustments which shall be as nearly
equivalent as may be practicable to the adjustments provided for in this Article 2
including, without limitation, adjustments to the Warrant Price and to the number of
securities or property issuable upon exercise of the new warrant. The provisions of this
Section 2.2 shall similarly apply to successive reclassifications, exchanges,
substitutions, or other events.

2.3  
Adjustments for Combinations, Etc. If the outstanding Shares are combined or
consolidated, by reclassification or otherwise, into a lesser number of shares, the
Warrant Price shall be proportionately increased. If the outstanding Shares are combined
or consolidated, by reclassification or otherwise, into a greater number of shares, the
Warrant Price shall be proportionately decreased.

2.4  
Adjustments for Diluting Issuances. The Warrant Price and the number of Shares
issuable upon exercise of this warrant shall be subject to adjustment, from time to time,
in the manner set forth on Exhibit A, if attached, in the event of Diluting Issuances (as
defined on Exhibit A).

2.5  
No Impairment. The Company shall not, by amendment of its Certificate of
Incorporation or through a reorganization, transfer of assets, consolidation, merger,
dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms to be observed or performed under
this warrant by the Company, but shall at all times in good faith assist in carrying out
all the provisions of this Article 2 and in taking all such action as may be necessary or
appropriate to protect Holders rights under this Article against impairment.

2.6  
Certificate as to Adjustments. Upon each adjustment of the Warrant Price, the
Company at its expense shall promptly compute such adjustment, and furnish Holder with a
certificate of its Chief Financial Officer setting forth such adjustment and the facts
upon which such adjustment is based. The Company shall, upon written request, furnish
Holder a certificate setting forth the Warrant Price in effect upon the date thereof and
the series of adjustments leading to such Warrant Price.

ARTICLE 3.  REPRESENTATIONS AND
COVENANTS OF THE COMPANY.

3.1  
Representations and Warranties. The Company hereby represents and warrants to the
Holder as follows:

(a)
          The initial Warrant Price referenced on the first page of this warrant is not
          greater than the fair market value of the Shares as of the date of this warrant.

(b)
          All Shares which may be issued upon the exercise of the purchase right
          represented by this warrant, and all securities, if any, issuable upon
          conversion of the Shares, shall, upon issuance, be duly authorized, validly
          issued, fully paid and nonassessable, and free of

-3-



---

any liens and encumbrances
          except for restrictions on transfer provided for herein or under applicable
          federal and state securities laws.

(c)
          The Companys capitalization table attached to this warrant is true and
          complete as of the Issue Date.

3.2  
Notice of Certain Events. If the Company proposes at any time (a) to declare
any dividend or distribution upon its common stock, whether in cash, property, stock, or
other securities and whether or not a regular cash dividend; (b) to offer for
subscription pro rata to the holders of any class or series of its stock any additional
shares of stock of any class or series or other rights; (c) to effect any
reclassification or recapitalization of common stock; or (d) to merge or consolidate
with or into any other corporation, or sell, lease, license, or convey all or
substantially all of its assets, or to liquidate, dissolve or wind up, then, in connection
with each such event, the Company shall give Holder (1) at least 15 days prior
written notice of the date on which a record will be taken for such dividend,
distribution, or subscription rights (and specifying the date on which the holders of
common stock will be entitled thereto) or for determining rights to vote, if any, in
respect of the matters referred to in (a) and above; and (2) in the case of the
matters referred to in (c) and (d) above at least 15 days prior written notice
of the date when the same will take place (and specifying the date on which the holders of
common stock will be entitled to exchange their common stock for securities or other
property deliverable upon the occurrence of such event).

3.3  
Information Rights. So long as the Holder holds this warrant and/or any of the
Shares, the Company shall deliver to the Holder (a) promptly after mailing, copies of
all communiqués to the shareholders of the Company, (b) within one hundred
twenty (120) days after the end of each fiscal year of the Company, the annual
audited financial statements of the Company certified by independent public accountants of
recognized standing and within forty-five (45) days after the end of each of the
first three quarters of each fiscal year, the Companys quarterly, unaudited
financial statements.

3.4  
Registration Under Securities Act of 1933, as amended. The Company agrees that the
Shares or, if the Shares are convertible into common stock of the Company, such common
stock, shall be subject to the registration rights set forth on Exhibit B.

ARTICLE 4.   MISCELLANEOUS.

4.1  
Term: Notice of Expiration. This warrant is exercisable in whole or in part, at any
time and from time to time on or before the Expiration Date set forth above. If this
warrant has not been exercised prior to the Expiration Date, this warrant shall be deemed
to have been automatically exercised on the Expiration Date by cashless
conversion pursuant to Section 1.2.

4.2  
Legends. This warrant and the Shares (and the securities issuable, directly or
indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in
substantially the following form:

THIS SECURITY HAS NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE
TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH

-4-



---

ACT OR PURSUANT TO RULE
144 OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION AND ITS COUNSEL
THAT SUCH REGISTRATION IS NOT REQUIRED.

4.3  
Compliance with Securities Laws on Transfer. This warrant and the Shares issuable
upon exercise of this warrant (and the securities issuable, directly or indirectly, upon
conversion of the Shares, if any) may not be transferred or assigned in whole or in part
without compliance with applicable federal and state securities laws by the transferor and
the transferee (including, without limitation, the delivery of investment representation
letters and legal opinions reasonably satisfactory to the Company). The Company shall not
require Holder to provide an opinion of counsel if the transfer is to an affiliate of
Holder or if there is no material question as to the availability of current information
as referenced in Rule 144(c), Holder represents that it has complied with Rule 144(d) and
(e) in reasonable detail, the selling broker represents that it has complied with
Rule 144(f), and the Company is provided with a copy of Holders notice of proposed
sale.

4.4  
Transfer Procedure. Subject to the provisions of Section 4.3, Holder may transfer
all or part of this warrant or the Shares issuable upon exercise of this warrant (or the
securities issuable, directly or indirectly, upon conversion of the Shares, if any) by
giving the Company notice of the portion of the warrant being transferred setting forth
the name, address and taxpayer identification number of the transferee and surrendering
this warrant to the Company for reissuance to the transferee(s) (and Holder, if
applicable); provided, however, that Holder may transfer all or part of this warrant to
its affiliates, including, without limitation, Comerica Incorporated, at any time without
notice to the Company, and such affiliate shall then be entitled to all the rights of
Holder under this warrant and any related agreements, and the Company shall cooperate
fully in ensuring that any stock issued upon exercise of this warrant is issued in the
name of the affiliate that exercises the warrant. The terms and conditions of this warrant
shall inure to the benefit of, and be binding upon, the Company and the holders hereof and
their respective permitted successors and assigns. The Company shall have the right to
refuse to transfer any portion of this warrant to any person who directly competes with
the Company.

4.5  
Notices. All notices and other communications from the Company to the Holder, or
vice versa, shall be deemed delivered and effective when given personally or mailed by
first-class registered or certified mail, postage prepaid, at such address as may have
been furnished to the Company or the Holder, as the case may be, in writing by the Company
or such Holder from time to time. All notices to the Holder shall be addressed as follows:

| | COMERICA BANK
Attn: Warrant Administrator
Technology and Life Sciences Division
P.O. Box 7279
San Francisco, CA 94120-7279
| | --------------------------------------------------------------------------------------------------------------------------

-5-



---

with a copy to

| | COMERICA BANK
Attn: Warrant Administrator
Technology and Life Sciences Division
5 Palo Alto Square, Suite 800
3000 El Camino Real
Palo Alto, CA 94306
| | -----------------------------------------------------------------------------------------------------------------------------------------------------

4.6  
Waiver. This warrant and any term hereof may be changed, waived, discharged or
terminated only by an instrument in writing signed by the party against which enforcement
of such change, waiver, discharge or termination is sought.

4.7  
Attorneys Fees. In the event of any dispute between the parties concerning
the terms and provisions of this warrant, the party prevailing in such dispute shall be
entitled to collect from the other party all costs incurred in such dispute, including
reasonable attorneys fees.

4.8  
Governing Law. This warrant shall be governed by and construed in accordance with
the laws of the State of California, without giving effect to its principles regarding
conflicts of law.

| | TCI SOLUTIONS, INC.                    
| | ---------------------------------------
|
| | By: /s/ Steve DeSantis_________________
|
| | Name:  Steve DeSantis_________________ 
|
| | Title: CFO__________________________   
|
| | By:________________________________    
|
| | Name:_____________________________     
|
| | Title:______________________________   
|

Authorized signatories under
Corporate Resolutions to Borrow or an authorized signer(s) under a resolution covering
warrants must sign the warrant.

-6-



---

APPENDIX 1

NOTICE OF EXERCISE

1.       
          The undersigned hereby elects to purchase ______________ shares of the
          ______________ stock of TCI SOLUTIONS, INC. pursuant to the terms of the
          attached warrant, and tenders herewith payment of the purchase price of such
          shares in full.

2.       
          The undersigned hereby elects to convert the attached warrant into shares in the
          manner specified in the warrant. This conversion is exercised with respect to
          ______________ of the shares covered by the warrant.

[Strike
paragraph that does not apply.]

2.       
          Please issue a certificate or certificates representing said shares in the name
          of the undersigned or in such other name as is specified below:

| | COMERICA BANK
Attn: Warrant Administrator 
Technology and Life Sciences Division 
5 Palo Alto Square, Suite 800 
P.O. Box 7279 
San Francisco, CA 94120-7279
| | ------------------------------------------------------------------------------------------------------------------------------------------------------------

3.       
          The undersigned represents it is acquiring the shares solely for its own account
          and not as a nominee for any other party and not with a view toward the resale
          or distribution thereof except in compliance with applicable securities laws.

COMERICA BANK or
Registered Assignee

____________________________
(Signature)

____________________________
(Date)

-7-



---

EXHIBIT A
  
COMERICA BANK ANTI-DILUTION AGREEMENT
(for Common Stock Warrants)

This
Anti-dilution Agreement is entered into as of February 27, 2004, by and between
COMERICA BANK (Purchaser) and TCI SOLUTIONS, INC. (the Company).

RECITALS

A.       
          Concurrently with the execution of this Anti-dilution Agreement, the Purchaser
          is purchasing from the Company a Warrant to Purchase Stock (the
          Warrant) pursuant to which Purchaser has the right to acquire from
          the Company the Shares (as defined in the Warrant).

B.       
          By this Anti-dilution Agreement, the Purchaser and the Company desire to set
          forth the adjustment in the number of Shares issuable upon exercise of the
          Warrant as a result of a Diluting Issuance (as defined below).

C.       
          Capitalized terms used herein shall have the same meaning as set forth in the
          Warrant.

NOW,
THEREFORE, in consideration of the mutual promises, covenants and conditions hereinafter
set forth, the parties hereto mutually agree as follows:

1.       
          Definitions. As used in this Anti-dilution Agreement, the following terms
          have the following respective meanings:

1.1
Option means any right, option or warrant to subscribe for, purchase or
otherwise acquire common stock or Convertible Securities.

1.2
Convertible Securities means any evidences of indebtedness, shares of stock or
other securities directly or indirectly convertible into or exchangeable for common stock.

1.3
Issue means to grant, issue, sell, assume or fix a record date for determining
persons entitled to receive any security (including Options), whichever of the foregoing
is the first to occur.

1.4
Additional Common Shares means all common stock (including reissued shares)
Issued (or deemed to be issued pursuant to Section 2) after the date of the Warrant.
Additional Common Shares does not include, however, any common stock Issued in a
transaction described in Sections 2.1, 2.2 and 2.3 of this Warrant; any common stock
Issued upon conversion of preferred stock issued or authorized to be issued as of the date
of the Warrant; or common stock Issued upon conversion of options, warrants or other
convertible securities, Issued as of the date of this Warrant; or common stock Issued upon
exercise of stock options Issued as incentive or in nonfinancing transaction to employees,
officers, directors or consultants to the Company.

-8-



---

2.       
          Deemed Issuance of Additional Common Shares. The shares of common stock
          ultimately Issuable upon exercise of an Option (including the shares of common
          stock ultimately Issuable upon conversion or exercise of a Convertible Security
          Issuable pursuant to an Option) are deemed to be Issued when the Option is
          Issued. The shares of common stock ultimately Issuable upon conversion or
          exercise of a Convertible Security (other than a Convertible Security Issued
          pursuant to an Option) shall be deemed Issued upon Issuance of the Convertible
          Security. The maximum amount of common stock Issuable is determined without
          regard to any future adjustments permitted under the instrument creating the
          Options or Convertible Securities.

3.       
          Adjustment of Warrant Price for Diluting Issuances.

3.1 Weighted Average Adjustment. If the Company issues Additional Common Shares after the date
of the Warrant and the consideration per Additional Common Share (determined pursuant to
Section 9) is less than the Warrant Price in effect immediately before such Issue (a
Diluting Issuance), the Warrant Price in effect immediately before such Issue
shall be reduced, concurrently with such Issue, to a price (calculated to the nearest
hundredth of a cent) determined by multiplying the Warrant Price by a fraction:

(a)
          the numerator of which is the amount of common stock outstanding immediately
          before such Issue plus the amount of common stock that the aggregate
          consideration received by Company for the Additional Common Shares would
          purchase at the Warrant Price in effect immediately before such Issue, and

(b)
          the denominator of which is the amount of common stock outstanding immediately
          before such Issue plus the number of such Additional Common Shares.

3.2 Adjustment of Number of Shares. Upon each adjustment of the Warrant Price, the
number of Shares Issuable upon exercise of the Warrant shall be increased to equal the
quotient obtained by dividing the product resulting from multiplying (i) the number
of Shares Issuable upon exercise of the Warrant and (ii) the Warrant Price, in each
case as in effect immediately before such adjustment, by (b) the adjusted Warrant
Price.

3.3 Securities Deemed Outstanding. For the purpose of this Section 3, all securities
Issuable upon exercise of any outstanding Convertible Securities or Options, Warrants, or
other rights to acquire securities of the Company shall be deemed to be outstanding.

4.       
          No Adjustment for Issuances Following Deemed Issuances. No adjustment to
          the Warrant Price shall be made upon the exercise of Options or conversion of
          Convertible Securities.

5.       
          Adjustment Following Changes in Terms of Options or Convertible
          Securities. If the consideration payable to, or the amount of common stock
          Issuable by, the Company increases or decreases, respectively, pursuant to the
          terms of any outstanding Options or Convertible Securities, the Warrant Price
          shall be recomputed to reflect such increase or decrease. The recomputation
          shall be made as of the time of the Issuance of the Options or Convertible
          Securities. Any changes in the Warrant Price that occurred after such Issuance
          because other Additional Common Shares were Issued or deemed Issued shall also
          be recomputed.

-9-



---

6.       
          Recomputation Upon Expiration of Options or Convertible Securities. The
          Warrant Price computed upon the original Issue of any Options or Convertible
          Securities, and any subsequent adjustments based thereon, shall be recomputed
          when any Options or rights of conversion under Convertible Securities expire
          without having been exercised. In the case of Convertible Securities or Options
          for common stock, the Warrant Price shall be recomputed as if the only
          Additional Common Shares Issued were the shares of common stock actually Issued
          upon the exercise of such securities , if any, and as if the only consideration
          received therefore was the consideration actually received upon the Issue,
          exercise or conversion of the Options or Convertible Securities. In the case of
          Options for Convertible Securities, the Warrant Price shall be recomputed as if
          the only Convertible Securities Issued were the Convertible Securities actually
          Issued upon the exercise thereof, if any, and as if the only consideration
          received therefore was the consideration actually received by the Company
          (determined pursuant to Section 9), if any, upon the Issue of the Options for
          the Convertible Securities.

7.       
          Limit on Readjustments. No readjustment of the Warrant Price pursuant to
          Sections 5 or 6 shall increase the Warrant Price more than the amount of any
          decrease made in respect of the Issue of any Options or Convertible Securities.

8.       
          30 Day Options. In the case of any Options that expire by their terms not
          more than 30 days after the date of Issue thereof, no adjustment of the Warrant
          Price shall be made until the expiration or exercise of all such Options.

9.       
          Computation of Consideration. The consideration received by the Company
          for the Issue of any Additional Common Shares shall be computed as follows:

(a)
          Cash shall be valued at the amount of cash received by the Corporation,
          excluding amounts paid or payable for accrued interest or accrued dividends.

(b)
          Property. Property, other than cash, shall be computed at the fair market
          value thereof at the time of the Issue as determined in good faith by the Board
          of Directors of the Company.

(c)
          Mixed Consideration. The consideration for Additional Common Shares
          Issued together with other property of the Company for consideration that covers
          both shall be determined in good faith by the Board of Directors.

(d)
          Options and Convertible Securities. The consideration per Additional
          Common Share for Options and Convertible Securities shall be determined by
          dividing:

(i)
          the total amount, if any, received or receivable by the Company for the Issue of
          the Options or Convertible Securities, plus the minimum amount of additional
          consideration (as set forth in the instruments relating thereto, without regard
          to any provision contained therein for a subsequent adjustment of such
          consideration) payable to the Company upon exercise of the Options or conversion
          of the Convertible Securities, by

(ii)
          the maximum amount of common stock (as set forth in the instruments relating
          thereto, without regard to any provision contained therein for a subsequent

-10-



---

adjustment of such number) ultimately Issuable upon the exercise of such Options
          or the conversion of such Convertible Securities.

10.       
          General.

10.1 Governing Law. This Anti-dilution Agreement shall be governed in all respects by
the laws of the State of California as such laws are applied to agreements between
California residents entered into and to be performed entirely within California.

10.2 Successors and Assigns. Except as otherwise expressly provided herein, the provisions
hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs,
executors and administrators of the parties hereto.

10.3 Entire Agreement. Except as set forth below, this Anti-dilution Agreement and the
other documents delivered pursuant hereto constitute the full and entire understanding and
agreement between the parties with regard to the subjects hereof and thereof.

10.4 Notices, etc. All notices and other communications required or permitted hereunder
shall be in writing and shall be mailed by first class mail, postage prepaid, certified or
registered mail, return receipt requested, addressed (a) if to Purchaser at
Purchasers address as set forth below, or at such other address as Purchaser shall
have furnished to the Company in writing, or (b) if to the Company, at the
Companys address set forth below, or at such other address as the Company shall have
furnished to the Purchaser in writing.

10.5 Severability. In case any provision of this Anti-dilution Agreement shall be
invalid, illegal or unenforceable, the validity, legality and enforceability of the
remaining provisions of this Anti-dilution Agreement shall not in any way be affected or
impaired thereby.

10.6 Titles and Subtitles. The titles of the sections and subsections of this Agreement
are for convenience of reference only and are not to be considered in construing this
Anti-dilution Agreement.

10.7 Counterparts. This Anti-dilution Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together shall
constitute one instrument.

|PURCHASER                                    |  | ISSUER                                      | 
|-------------------------------------------- |  | ------------------------------------------- | 
|                                             |  |                                             | 
|COMERICA BANK                                |  | TCI SOLUTIONS, INC.                         | 
|                                             |  |                                             | 
|By:_______________________________________   |  | By:______________________________________   | 
|                                             |  |                                             | 
|Name:_____________________________________   |  | Name:____________________________________   | 
|                                             |  |                                             | 
|Title:______________________________________ |  | Title:_____________________________________ | 
|                                             |  |                                             | 
|Address:___________________________________  |  | Address:__________________________________  | 

-11-



---

EXHIBIT B

Registration Rights

The
Shares shall be deemed registrable securities entitled to piggy
back registration rights in accordance with Section 4 of the following agreement (t
he Agreement) between the Company and its investor(s):

> SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, dated as of April 10, 2002
> (as amended from time to time)

The
Shares shall not be entitled to any registration rights other than the piggy
back rights set forth in Section 4 of the Agreement. The Company agrees that no
amendments will be made to the Agreement, which would have an adverse impact on
Holders registration rights thereunder without the consent of Holder. By acceptance
of the Warrant to which this Exhibit B is attached, Holder shall be deemed to be a party
to the Agreement and bound by the obligations thereunder.

-12-